Net Cash Provided by (Used in) Operating Activities |
-415K |
USD |
-1.32% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
579K |
USD |
+189% |
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q1 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
20.1M |
shares |
+9.08% |
Q1 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
163K |
USD |
|
Q4 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
86.5K |
USD |
-77.5% |
Q4 2022 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
589K |
USD |
+17% |
Q3 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2022 |
Q1 2023 |
Deferred Tax Assets, Gross |
589K |
USD |
+17% |
Q3 2023 |
FY 2023 |
Depreciation |
1.83K |
USD |
0% |
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
589K |
USD |
+17% |
Q3 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
9 |
shares |
|
Q4 2022 |
Q1 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q1 2024 |
Q2 2024 |
Additional Paid in Capital |
19M |
USD |
+28.6% |
Q1 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
9 |
shares |
|
Q4 2022 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2022 |
FY 2022 |
Interest Expense |
49K |
USD |
-91.7% |
Q1 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q2 2024 |